Market capitalisation, EUR | 446.68 m |
EPS, EUR | -3.29 |
P/B ratio | 1.83 |
P/E ratio | - |
Dividend yield | 0.00% |
Revenue, EUR | 259.30 m |
Net income, EUR | -176.01 m |
Profit margin | -67.88% |
ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
---|---|---|---|---|---|---|---|---|
L&G Global Thematic ESG Exclusions UCITS ETF USD Accumulating | 0.21% | Equity World Social/Environmental Innovation | 361 | 0.60% | 4 | +6.26% | A3DHPA | IE000VTOHNZ0 |
Global X Genomics & Biotechnology UCITS ETF | 0.75% | Equity World Health Care Biotech | 41 | 0.50% | 6 | -13.14% | A2QRCP | IE00BM8R0N95 |
iShares Healthcare Innovation UCITS ETF | 0.09% | Equity World Health Care Social/Environmental Innovation | 195 | 0.40% | 979 | +1.18% | A2ANH2 | IE00BYZK4776 |
Xtrackers Russell 2000 UCITS ETF 1C | 0.02% | Equity United States Small Cap | 1,486 | 0.30% | 924 | +19.70% | A1XEJT | IE00BJZ2DD79 |
SPDR Russell 2000 US Small Cap UCITS ETF | 0.02% | Equity United States Small Cap | 1,795 | 0.30% | 2,509 | +19.55% | A1XFN1 | IE00BJ38QD84 |
L&G Healthcare Breakthrough UCITS ETF USD Acc | 1.43% | Equity World Health Care Innovation | 68 | 0.49% | 64 | -8.68% | A2PM51 | IE00BK5BC677 |